{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:32:51Z","timestamp":1787002371284,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T00:00:00Z","timestamp":1317340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T00:00:00Z","timestamp":1317340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/cgt.2011.65","type":"journal-article","created":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T06:22:57Z","timestamp":1317363777000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Tumor-targeted gene therapy using Adv-AFP-HRPC\/IAA prodrug system suppresses growth of hepatoma xenografted in mice"],"prefix":"10.1038","volume":"19","author":[{"given":"M","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-E","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z-J","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-Z","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Y","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,30]]},"reference":[{"key":"BFcgt201165_CR1","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HM El-serag","year":"2007","unstructured":"El-serag HM, Rudolph KL . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557\u20132576.","journal-title":"Gastroenterology"},{"key":"BFcgt201165_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1440-1746.2009.05784.x","volume":"24","author":"MF Yuen","year":"2009","unstructured":"Yuen MF, Hou JL, Chutaputti A . Epidemiology of hepatocellular carcinoma in Asia-Pacific region. J Gastroenterol Hepatol 2009; 24: 346\u2013353.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcgt201165_CR3","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.3748\/wjg.v12.i45.7239","volume":"12","author":"F Lodato","year":"2006","unstructured":"Lodato F, Mazzella G, Festi D . Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic contraints of developing nations. World J Gastroenterol 2006; 12: 7239\u20137249.","journal-title":"World J Gastroenterol"},{"key":"BFcgt201165_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(08)60181-6","volume":"371","author":"P Hainaut","year":"2008","unstructured":"Hainaut P, Boyle P . Curbing the liver cancer epidemic in Africa. Lancet 2008; 371: 367\u2013368.","journal-title":"Lancet"},{"key":"BFcgt201165_CR5","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.3748\/wjg.14.4300","volume":"14","author":"AL Gomaa","year":"2008","unstructured":"Gomaa AL, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD . Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastro 2008; 14: 4300.","journal-title":"World J Gastro"},{"key":"BFcgt201165_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1440-1746.2005.04043.x","volume":"21","author":"NI Herath","year":"2006","unstructured":"Herath NI, Leggett BA, Macdonald GA . Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastro Hepato 2006; 21: 15\u201321.","journal-title":"J Gastro Hepato"},{"key":"BFcgt201165_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1445-5994.2007.01439.x","volume":"37","author":"D Koorey","year":"2007","unstructured":"Koorey D . Hepatocellular carcinoma: prevention, detection and treatment in the real world. Intern med J 2007; 37: 513\u2013515.","journal-title":"Intern med J"},{"key":"BFcgt201165_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","volume":"353","author":"DF Schafer","year":"1999","unstructured":"Schafer DF, Sorrell MF . Hepatocellular carcinoma. Lancet 1999; 353: 1253\u20131257.","journal-title":"Lancet"},{"key":"BFcgt201165_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85\u201386.","journal-title":"Lancet"},{"key":"BFcgt201165_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M et al. T lymphocyte -directed gene therapy for ADA-deficiency SCID: initial trial results after 4 years. Science 1995; 270: 475\u2013480.","journal-title":"Science"},{"key":"BFcgt201165_CR11","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.3390\/molecules14114517","volume":"14","author":"GU Dach","year":"2009","unstructured":"Dach GU, Hunt MA, Syddoll S, Singleton DC, Patterson AV . Bystander or no bystander for gene directed enzyme prodrug therapy. Molecules 2009; 14: 4517\u20134545.","journal-title":"Molecules"},{"key":"BFcgt201165_CR12","first-page":"151","volume":"1","author":"O Greco","year":"2001","unstructured":"Greco O, Rossiter S, Kanthou C, Folkes LK, Wardman P, Tozer GM et al. Horseradish peroxidase-mediated gene therapy:choice of prodrugs in oxic and anoxic tumor conditions. Mol Cancer Therapeut 2001; 1: 151\u2013160.","journal-title":"Mol Cancer Therapeut"},{"key":"BFcgt201165_CR13","first-page":"478","volume":"40","author":"O Greco","year":"1999","unstructured":"Greco O, Dachs GU, Wardman P, Folkes LK, Chaplin DJ . Development of an enzyme\/prodrug combination for gene therapy of cancer. Proc Am Assoc Cancer Res 1999; 40: 478.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BFcgt201165_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0006-2952(00)00498-6","volume":"6","author":"LK Folkes","year":"2001","unstructured":"Folkes LK, Wardman P . Oxidative activation of indole-3-acetic acids to cytotoxic species\u2014a potential new role for plant auxins in cancer therapy. Biochem Pharmacol 2001; 6: 129\u2013136.","journal-title":"Biochem Pharmacol"},{"key":"BFcgt201165_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3181\/00379727-93-22678","volume":"93","author":"LA Mirsky","year":"1956","unstructured":"Mirsky LA, Diengott D . Hypoglycemic action of indole-3-acetic acid by mouth in patients with diabetes mellitus. Proc Soc Exp Biol Med 1956; 93: 109\u2013110.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BFcgt201165_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0360-3016(98)00297-1","volume":"42","author":"LK Folkes","year":"1998","unstructured":"Folkes LK, Candeias LP, Wardman P . Towards targeted \u201coxidation therapy\u201d of cancer: peroxidase-catalyzed cytotoxicity of indole -3-acetic acids. Int J Raduat Oncol Biol Phys 1998; 42: 917\u2013920.","journal-title":"Int J Raduat Oncol Biol Phys"},{"key":"BFcgt201165_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1751-1097.1997.tb08567.x","volume":"65","author":"M Pires de Melo","year":"1997","unstructured":"Pires de Melo M, Pithon Curi TC, Curi R, Di Mascio P, Cliento G . Peroxidase activity may play a role in the cytotoxic effect of indole acetic acid. Photochem Photobiol 1997; 65: 338\u2013341.","journal-title":"Photochem Photobiol"},{"key":"BFcgt201165_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0306-3623(98)00032-9","volume":"31","author":"M Pires de Melo","year":"1998","unstructured":"Pires de Melo M, Pithon Curi TC, Miyasaka CK, Palanch AC, Curi R . Effect of indole acetic acid on oxygen metabolism in cultured rat neutrophil. Gen Pharmacol 1998; 31: 573\u2013578.","journal-title":"Gen Pharmacol"},{"key":"BFcgt201165_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0898-6568(03)00091-3","volume":"16","author":"DS Kim","year":"2004","unstructured":"Kim DS, Jeon SE, Park KC . Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells. Cell Signal 2004; 16: 81\u201388.","journal-title":"Cell Signal"},{"key":"BFcgt201165_CR20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1089\/hum.1996.7.13-1503","volume":"7","author":"PB Arbuthnot","year":"1996","unstructured":"Arbuthnot PB, Bralet MP, Le Jossic C, Dedieu JF, Perricaudet M, Brechot C . In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther 1996; 7: 1503\u20131514.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201165_CR21","first-page":"301","volume":"5","author":"F Mawatari","year":"1998","unstructured":"Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y et al. Retrovirus-mediated gene therapy of hepatocellular carcinoma:selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 1998; 5: 301\u2013306.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201165_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1505","volume":"37","author":"ZL Mamie","year":"2005","unstructured":"Mamie ZL, Elledge SJ . MAGIC, an in vivo genetic method for the rapid construction of recombinant DNA molecules. Nature Genet 2005; 37: 311\u2013319.","journal-title":"Nature Genet"},{"key":"BFcgt201165_CR23","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/nar\/gkl449","volume":"34","author":"R Tan","year":"2006","unstructured":"Tan R, Li CH, Jiang SJ, Ma LX . A novel and simple method for construction of recombinant adenoviruses. Nucleic Acids Res 2006; 34: e89.","journal-title":"Nucleic Acids Res"},{"key":"BFcgt201165_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1172\/JCI0210623","volume":"109","author":"H Nakamure","year":"2002","unstructured":"Nakamure H, Kasuya H, Mullen JT, Yoon SS, Chandrasekhar S, Donahue JM et al. Regulation of herpes simplex virus \u03b3(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5. J Clin Invest 2002; 109: 871\u2013882.","journal-title":"J Clin Invest"},{"key":"BFcgt201165_CR25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","volume":"15","author":"Y Fong","year":"1997","unstructured":"Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938\u2013946.","journal-title":"J Clin Oncol"},{"key":"BFcgt201165_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/bjs.1800790309","volume":"79","author":"Y Panis","year":"1992","unstructured":"Panis Y, Ribeiro J, Chretien Y, Nordlinger B . Dormant liver metastases: An experimental study. Br J Surg 1992; 79: 221\u2013223.","journal-title":"Br J Surg"},{"key":"BFcgt201165_CR27","first-page":"993","volume":"60","author":"R Gerolami","year":"2000","unstructured":"Gerolami R, Cardoso J, Lewin M, Bralet MP, Sa Cunha A, Clement O et al. Evaluation of HSV-tk gene therapy in rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes. Cancer Res 2000; 60: 993\u20131001.","journal-title":"Cancer Res"},{"key":"BFcgt201165_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2008.01.027","volume":"264","author":"KC Xiao","year":"2008","unstructured":"Xiao KC, Jun LZ, Ying C, Xue MS, Pei YL, Jun SL . Targeting gene therapy for hepatocarcinoma cells with the E.coli purine nucleoside phosphorylase suicide gene system directed by a chimeric \u03b1-fetoprotein promoter. Cancer Lett 2008; 264: 71\u201382.","journal-title":"Cancer Lett"},{"key":"BFcgt201165_CR29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1248\/bpb.29.1625","volume":"29","author":"DS Kim","year":"2006","unstructured":"Kim DS, Kim SY, Jeong YM, Jeon SE, Kim MK, Kuon SB et al. Indole-3-acetic acid\/horseradish peroxidase-induced apoptosis involves cell sulface CD95 (Fas\/Apo-1) expression. Biol Pharm Bull 2006; 29: 1625\u20131629.","journal-title":"Biol Pharm Bull"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T08:40:01Z","timestamp":1647938401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFcgt201165"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2011.65","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,30]]},"assertion":[{"value":"30 June 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}